Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Pfizenmaier

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Bioconjugate Chemistry|April 29, 2014
Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticlesOliver Seifert, Nadine Pollak, Anja Nusser, et al.
Oncotarget|March 16, 2018
Targeting scFv-Fc-scTRAIL fusion proteins to tumor cellsMeike Hutt, Sina Fellermeier-Kopf, Oliver Seifert, et al.
Molecular Biology of the Cell|December 17, 2013
Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinasesChristoph Wille, Conny Köhler, Milena Armacki, et al.
The Biochemical Journal|August 19, 2011
Protein kinase D controls voluntary-running-induced skeletal muscle remodellingKornelia Ellwanger, Christine Kienzle, Sylke Lutz, et al.
Cancer Research|February 11, 2010
Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancerChristian M Joffroy, Miriam B Buck, Matthias B Stope, et al.
Traffic (Copenhagen, Denmark)|May 7, 2009
A Golgi PKD activity reporter reveals a crucial role of PKD in nocodazole-induced Golgi dispersalYannick F Fuchs, Stephan A Eisler, Gisela Link, et al.
Mabs|September 26, 2018
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activityFabian Richter, Kirstin A Zettlitz, Oliver Seifert, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 23, 2006
A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95Constance Assohou-Luty, Jeanette Gerspach, Daniela Siegmund, et al.
Protein Engineering, Design & Selection : PEDS|September 6, 2013
An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF actionVerena Berger, Fabian Richter, Kirstin Zettlitz, et al.
Molecular Cancer Therapeutics|September 15, 2017
Superior Properties of Fc-comprising scTRAIL Fusion ProteinsMeike Hutt, Lisa Marquardt, Oliver Seifert, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Bioconjugate Chemistry|April 29, 2014
Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticlesOliver Seifert, Nadine Pollak, Anja Nusser, et al.
Oncotarget|March 16, 2018
Targeting scFv-Fc-scTRAIL fusion proteins to tumor cellsMeike Hutt, Sina Fellermeier-Kopf, Oliver Seifert, et al.
Molecular Biology of the Cell|December 17, 2013
Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinasesChristoph Wille, Conny Köhler, Milena Armacki, et al.
The Biochemical Journal|August 19, 2011
Protein kinase D controls voluntary-running-induced skeletal muscle remodellingKornelia Ellwanger, Christine Kienzle, Sylke Lutz, et al.
Cancer Research|February 11, 2010
Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancerChristian M Joffroy, Miriam B Buck, Matthias B Stope, et al.
Traffic (Copenhagen, Denmark)|May 7, 2009
A Golgi PKD activity reporter reveals a crucial role of PKD in nocodazole-induced Golgi dispersalYannick F Fuchs, Stephan A Eisler, Gisela Link, et al.
Mabs|September 26, 2018
Monovalent TNF receptor 1-selective antibody with improved affinity and neutralizing activityFabian Richter, Kirstin A Zettlitz, Oliver Seifert, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 23, 2006
A CD40-CD95L fusion protein interferes with CD40L-induced prosurvival signaling and allows membrane CD40L-restricted activation of CD95Constance Assohou-Luty, Jeanette Gerspach, Daniela Siegmund, et al.
Protein Engineering, Design & Selection : PEDS|September 6, 2013
An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF actionVerena Berger, Fabian Richter, Kirstin Zettlitz, et al.
Molecular Cancer Therapeutics|September 15, 2017
Superior Properties of Fc-comprising scTRAIL Fusion ProteinsMeike Hutt, Lisa Marquardt, Oliver Seifert, et al.
Pageof 10